1. Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial. Issue 2 (1st February 2021) Authors: Mennitto, A.; Verzoni, E.; Cognetti, F.; Miceli, R.; Milella, M.; Mosca, A.; Chiuri, V. E.; Bearz, A.; Morelli, F.; Ortega, C.; Atzori, F.; Donini, M.; Claps, M.; Guadalupi, V.; Sepe, P.; Cappelletti, V.; de Braud, F. G.; Procopio, G. Journal: Expert review of clinical pharmacology Issue: Volume 14:Issue 2(2021) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗